Melatonin treatment is beneficial in pancreatic repair process after experimental acute pancreatitis.
Current treatment options for acute pancreatitis are supportive and symptomatic. Due to lack of agents targeting the underlying pathophysiology a large amount of experimental work is going on to identify novel therapeutic agents. The present study was carried out to explore if melatonin can modulate the spontaneous regeneration process of the pancreas after experimentally induced acute pancreatitis. Rats were given two i.p. injections of l-arginine in a dose of 200mg/100g at an interval of 1h for induction of pancreatitis. After this rats were randomly divided into three groups i.e. saline, CCK-8 and melatonin. Drug treatment was started 2h after the last l-arginine injection and continued till the day of sacrifice. An additional only saline treated control group was included for comparison. Animals in each group were sacrificed at 24h, days 3, 14 and 28 after pancreatitis induction for determination of biochemical parameters (serum amylase, lipase and IL-10 and pancreatic amylase, total proteins and nucleic acid content) and histological examination. For rate of DNA synthesis and immunohistochemical studies animals were sacrificed at day 3 and day 7. Melatonin treatment was found to be beneficial in acute pancreatitis. Severity of acute pancreatitis was significantly reduced in melatonin group. Nucleic acid content, rate of DNA synthesis, pancreatic proteins and pancreatic amylase content were significantly improved. Histopathological examination showed significantly lower total scores in melatonin group. Results of melatonin group were comparable to that of positive control, CCK-8 group. Thus melatonin treatment was found to promote the spontaneous regeneration process of pancreatic tissue.
Sidhu
Shabir
S
Department of Pharmacology, Post Graduate Institute of Medical Education and Research, Chandigarh, India. sidhushabir@rediffmail.com
Pandhi
Promila
P
Malhotra
Samir
S
Vaiphei
Kim
K
Khanduja
K L
KL
D000681:Amylases / Q000097:blood / Q000378:metabolism; D000818:Animals; D004247:DNA / Q000096:biosynthesis; D004195:Disease Models, Animal; D005260:Female; D005786:Gene Expression Regulation / Q000187:drug effects; D007150:Immunohistochemistry; D016753:Interleukin-10 / Q000097:blood; D007700:Kinetics; D008049:Lipase / Q000097:blood; D008297:Male; D008550:Melatonin / Q000494:pharmacology*; D009696:Nucleic Acids / Q000378:metabolism; D010179:Pancreas / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism / Q000503:physiopathology*; D010195:Pancreatitis / Q000097:blood / Q000201:enzymology / Q000378:metabolism / Q000503:physiopathology*; D011506:Proteins / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D012038:Regeneration / Q000187:drug effects*; D020133:Reverse Transcriptase Polymerase Chain Reaction
D009696:Nucleic Acids; D011506:Proteins; D016753:Interleukin-10; D004247:DNA; D008049:Lipase; D000681:Amylases; D008550:Melatonin